# Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

> **NCT02735031** · PHASE2,PHASE3 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Hypoglycemia

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02735031
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-21
- **Primary completion:** 2018-03-28
- **Final completion:** 2018-04-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02735031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02735031, "Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02735031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*